Home›Companies›Biotech & Pharma›Revi Life Sciences

Revi Life Sciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 7, 2025·Suggest an edit

About Revi Life Sciences

Revi Life Sciences is a private company based in Austin, Texas, incorporated in 2023 in Texas. It has reported $340,000 raised in one offering on Form D since April 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 22, 2025Apr 7, 2025amended Apr 7, 2025$340,000target not set9$37,778Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Revi Life Sciences's Form D filed Apr 7, 2025.

JE
Jason Eades
Executive officer and director

Sources

  1. SECREVI LIFE SCIENCES, INC. Form D, filed Apr 7, 2025
  2. SECREVI LIFE SCIENCES, INC. filing history